ILMN – Illumina Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

Illumina Inc.

Healthcare
Diagnostics & Research
302.69
18.45
6.49%
367.06
209.54
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)4.62
EPS Estimate Currrent Qtr1.35
Book Value Per Share23.83
Market Cap 44 Billion
PE Ratio 59
Dividend YieldNA

Stock Yield

Stock Return 7 Days9.46%
Stock Return 15 Days-4.07%
Stock Return 30 Days -14.85%
Stock Return 3 Months-17.65%
Stock Return One Year33.12%
Stock Return 3 Years33.88%

Stock Technical Analysis

Relative Strengh Index (14)27.22
Average True Range (14)13.53
Momentum (14)-52.68
Simple Moving Average (14) -52.68
Time Series Forecast (14)279.07
Time Series Forecast (30) 342.98

Stock News

Financial Statements

index2014201520162017
Revenue2 Billion2 Billion2 Billion3 Billion
Cost of Revenue564 Million671 Million732 Million926 Million
Gross Profit1 Billion2 Billion2 Billion2 Billion
Gross Margin (%)69.72%69.77%69.47%66.35%
Selling General and Administrative Expense466 Million516 Million584 Million674 Million
Other operating expenses341 Million403 Million453 Million24 Million
Earning Before Interest and Taxes EBIT490 Million630 Million629 Million1 Billion
EBIT/Operating Margin (%)26.35%28.38%26.23%40.99%
Interest Expense42 Million43 Million33 Million37 Million
Other non-operating expenses/income0000
Earnings before Tax449 Million587 Million596 Million1 Billion
Income Tax Expense95 Million125 Million133 Million365 Million
Net Income353 Million462 Million463 Million726 Million
Net Margin (%)18.98%20.81%19.31%26.38%
Earnings per share from operating income0.5856960.4398830.4425180.315797
Earnings per Diluted Share2.373.13.074.92
Dividends per Basic Common Share0000
Weighted average number of shares outstanding149 Million149 Million151 Million148 Million
index2017 Q42018 Q12018 Q22018 Q3
Revenue777 Million782 Million830 Million853 Million
Cost of Revenue235 Million244 Million255 Million256 Million
Gross Profit542 Million538 Million575 Million597 Million
Gross Margin (%)69.76%68.80%69.28%69.99%
Selling General and Administrative Expense175 Million183 Million197 Million197 Million
Other operating expenses122 Million112 Million126 Million142 Million
Earning Before Interest and Taxes EBIT245 Million243 Million252 Million258 Million
EBIT/Operating Margin (%)31.53%31.07%30.36%30.25%
Interest Expense11 Million11 Million11 Million15 Million
Other non-operating expenses/income0000
Earnings before Tax234 Million232 Million241 Million243 Million
Income Tax Expense166 Million24 Million32 Million44 Million
Net Income68 Million208 Million209 Million199 Million
Net Margin (%)8.75%26.60%25.18%23.33%
Earnings per share from operating income7.665830.828560.8551360.974799
Earnings per Diluted Share0.471.411.411.33
Dividends per Basic Common Share0000
Weighted average number of shares outstanding145 Million148 Million148 Million150 Million
index2014201520162017
Cash and Equivalents636 Million769 Million735 Million1 Billion
Trade and Non Trade Receivables289 Million386 Million381 Million411 Million
Inventory191 Million271 Million300 Million333 Million
Other current assets2 Billion2 Billion2 Billion3 Billion
Current Assets2 Billion2 Billion2 Billion3 Billion
Total Non-Current Assets1 Billion2 Billion2 Billion2 Billion
Total Assets3 Billion4 Billion4 Billion5 Billion
Trade and Non Trade Payables83 Million139 Million138 Million160 Million
Other current liabilities640 Million471 Million567 Million586 Million
Current Liabilities722 Million610 Million705 Million746 Million
Liabilities Non Current1 Billion1 Billion1 Billion2 Billion
Accumulated Retained Earnings Deficit561 Million1 Billion1 Billion2 Billion
Shareholder’s equity other902 Million826 Million712 Million493 Million
Shareholders Equity1 Billion2 Billion2 Billion3 Billion
Noncontrolling interests1 Billion1 Billion1 Billion1 Billion
Total Assets3 Billion4 Billion4 Billion5 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents1 Billion2 Billion1 Billion1 Billion
Trade and Non Trade Receivables411 Million400 Million395 Million433 Million
Inventory333 Million350 Million362 Million374 Million
Other current assets3 Billion4 Billion4 Billion5 Billion
Current Assets3 Billion3 Billion3 Billion4 Billion
Total Non-Current Assets2 Billion2 Billion3 Billion2 Billion
Total Assets5 Billion6 Billion6 Billion7 Billion
Trade and Non Trade Payables160 Million151 Million149 Million156 Million
Other current liabilities586 Million1 Billion1 Billion2 Billion
Current Liabilities746 Million1 Billion1 Billion2 Billion
Liabilities Non Current2 Billion1 Billion1 Billion1 Billion
Accumulated Retained Earnings Deficit2 Billion2 Billion3 Billion3 Billion
Shareholder’s equity other493 Million544 Million584 Million631 Million
Shareholders Equity3 Billion3 Billion3 Billion4 Billion
Noncontrolling interests1 Billion2 Billion3 Billion4 Billion
Total Assets5 Billion6 Billion6 Billion7 Billion
index2014201520162017
Net Cash Flow from Operations501 Million786 Million779 Million875 Million
Capital Expenditure-142 Million-143 Million-271 Million-312 Million
Net Cash Flow from Investing-407 Million-107 Million-515 Million-214 Million
Net Cash Flow from Financing-167 Million-545 Million-296 Million-176 Million
Cash and Equivalents636 Million769 Million735 Million1 Billion
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations294 Million255 Million295 Million292 Million
Capital Expenditure-76 Million-90 Million-77 Million-64 Million
Net Cash Flow from Investing-315 Million12 Million-537 Million-940 Million
Net Cash Flow from Financing-109 Million67 Million30 Million651 Million
Cash and Equivalents1 Billion2 Billion1 Billion1 Billion

Stock Price History

table